The aim of this study was to develop a method for quantitative measurement of urinary metabolites of pyrethroid (PYR) insecticides, trans-chrysanthemumdicarboxylic acid (CDCA) and 3-phenoxybenzoic acid (3-PBA), extracted from disposable diapers. This study was approved by the university ethics committees, and informed consent was obtained from all the parents for their children and from adult volunteers. After extraction of PYR metabolites in the absorber of diapers with 5 ml acetone, the metabolites in the eluents were extracted with tert-butyl methyl ether, derivatized with 1,1,1,3,3,3-hexafluoroisopropanol and analyzed by gas chromatography-mass spectrometry. The limits of quantitation (LOQs) were 0.55 mg/l for CDCA and 0.09 mg/l for 3-PBA in 2 ml urine extracted from diapers. Within-series and between-day precisions were o14% (CV%) over the concentration range of metabolites from 0.4 to 20.4 mg/l urine. When concentrations of each metabolite were measured with the developed method after pouring 2 ml urine, which was obtained from adults both in a general population and pest control operators, on diapers, good correlations were shown between the measured results and the concentrations measured directly for the respective urine with the conventional method (Spearman's rank correlation coefficient 0.889 for CDCA and 0.989 for 3-PBA; n ¼ 27-28). The developed method would be applicable to epidemiological studies.
INTRODUCTION
The effects of chemical exposure on children's health have been drawing worldwide attention. Exposure measurement comprises an indispensable component of epidemiological studies investigating the relationship between exposure to environmental chemicals and children's health. In these studies urine is preferentially used as biomonitoring samples based on its advantage that collection is more feasible compared with other biological media. Theoretically, urine can be collected non-invasively from almost everyone, including diapered children. However, previous epidemiological studies monitoring chemical substances and their metabolites in urine have mostly been conducted for those aged Z2 years; special arrangements are needed to collect urine samples, especially from diapered children who cannot control their urination.
Use of urine collection bags devised primarily for clinical purposes is a currently available option. Unfortunately, there are a few drawbacks to this method. For some babies the adhesive on the collection bag may irritate the skin and elicit rashes. Moreover, urine can leak out via interspaces of the adhesive and skin surface. These drawbacks could be a hindrance to the recruitment of study subjects. Therefore, a method of simple, safe and less uncomfortable urinary collection from children who cannot control their urination is eagerly awaited. One possible solution is to use disposable diapers to collect urine for biomonitoring. Its greatest advantage is that a large number of disposable diaper samples can be collected easily from diapered children with little effort by parents.
Insecticides are environmental chemicals widely used in agricultural settings, public health, commerce and individual households throughout the world. Among them, synthetic pyrethroids (PYRs) have today become the most frequently applied insecticides for indoor or domestic usage. 1 In mammalian bodies, absorbed PYRs are biologically hydrolyzed, and their metabolites are excreted into urine via glucuronidation and other conjugation process. 2, 3 Some metabolites such as 3-phenoxybenzoic acid (3-PBA) and trans-chrysanthemumdicarboxylic acid (CDCA) are the ones into which almost all of the PYRs used as household insecticides and pesticides in Japan are metabolized. [4] [5] [6] These metabolites are the most sensitive biomarkers for exposure to environmental PYRs. Figure 1 shows the relationship between commonly measured metabolites and their parent compounds.
Some methodological studies for PYR metabolite assay have been developed over the past decade. [7] [8] [9] However, the level of actual PYR exposure in the daily life of the diapered children is poorly understood. To facilitate biomonitoring of PYR exposure levels in the children, only Hu et al. 10 have attempted to use disposable diaper samples so far to measure three PYR metabolites, 3-PBA, 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid and cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid. Nevertheless, this method has not been used practically due, in part, to the necessity of a large volume of solvent (100 ml CaCl 2 water per sample) and the difficulty in applying the extracting procedure to high-throughput measurement.
The aim of this study was to develop a simple and innovative method, compared with the one previously published, 7 for the detection and quantitation of urinary CDCA and 3-PBA in disposable diaper samples.
MATERIALS AND METHODS Ethics
The Ethics Committees of Nagoya University Graduate School of Medicine, Tohoku University Graduate School of Medicine and Nagoya City University Graduate School of Medical Sciences approved the study protocol. Before enrollment in the study, written informed consent with no remuneration for parents of children and for adult volunteers was obtained.
Reagents 3-PBA (99% purity) and 2-PBA (98% purity), used for an internal standard (IS), were purchased from Wako Pure Chemical Industries (Osaka, Japan).
CDCA (98.9% purity) was synthesized at Sumika Technoservice Corporation (Hyogo, Japan). 1,1,1,3,3,3-hexafluoroisopropanol (HFIP), N,N-diisopropylcarbodiimide (DIC), tert-butyl methyl ether, sodium hydrogen carbonate and iso-octane were from Sigma-Aldrich (St. Louis, MO, USA). Water used throughout the experiments was distilled and de-ionized to 18 MO with a Millipore Milli-Q System (Millipore, Bedford, MA, USA). All other reagents were of analytical grade purity. There are some differentiations of diaper component materials as shown in Table 1 . Therefore, five commercial diaper products made by three global companies were used to determine the optimal condition of urine extraction from the diaper.
Preparation of Standard Solutions
Pooled urine was collected from three healthy volunteers (two students and a staff member of Nagoya University, 25-33 years old), and used for matrix-matched calibration curves. We confirmed that slopes of calibration curves using pooled urine from three adults and three children (all 3 years old) were approximately the same. The baseline concentrations of CDCA and 3-PBA in the pooled urine were below the limit of detection (LOD) and 0.4 mg/l, respectively. Standard CDCA and 3-PBA were dissolved into acetonitrile at a concentration of 500 mg/l using a 100-ml measuring flask, and diluted with acetonitrile to each working standard solution. The additive volume of the working standard solution was controlled to account for o1% of the pooled urine volume to minimize the change of urine composition. Prepared standard urine samples were stored at À 45 1C until assay.
Analytical Procedure
Determination of urinary PYR metabolites from used diapers is called the ''diaper method'' in this study. On the other hand, the determination Figure 1 . Synthetic pyrethroids and their urinary metabolites (shaded areas) measured for biological monitoring. This figure was adapted from Ueyama et al. 20 with slight modifications. CDCA, chrysanthemumdicarboxylic acid; 3-PBA, 3-phenoxybenzoic acid. The analytical procedure for PYR metabolite measurement using disposable diapers is shown in Figure 2 . Approximately 2 g of the urine absorber (polyacrylate polymers and flocculent pulp as shown in Figure 3 ) containing urine was removed from the diapers into a solid-phase extraction (SPE) column and weighed (wet weight). The urine sample in the absorber was eluted with 5 ml acetone at a flow rate of 1 ml/min. The eluate was evaporated at 40 1C (heat block) with a gentle nitrogen stream down to r2 ml, and the volume was adjusted to 2 ml with distilled water.
After urine extraction with acetone, the urine absorber in the SPE column was dried in a vacuum state for B1 h and weighed (dry weight). Then, the volume of urine in the absorber was evaluated as the difference of wet and dry weight of the urine absorber.
The PYR metabolites in the urine extracted from the absorber were determined by the gas chromatography/mass spectrometry (GC/MS) system according to the previously established method 3 with slight modifications. Briefly, 2 ml urine samples from the absorber were transferred into a 15 ml screw-top glass test tube, and 20 ml IS solution (10 mg 2-PBA/ml acetonitrile) and 500 ml HCl (6 mol/l) were added. After gentle shaking, the test tube was incubated at 100 1C in a heat block for hydrolysis, and cooled on ice. Then, 3 ml of tert-butyl methyl ether was added to the test tube, and the mixture was shaken vigorously for 10 min and centrifuged for 5 min at 2000 Â g. The organic phase (upper layer) was transferred into a new screw-cap test tube. The residue was re-extracted with 3 ml tert-butyl methyl ether, shaken and centrifuged. The supernatant obtained from the second extraction was combined with the first extract. The resulting extract was evaporated at 40 1C (heat block) to dryness with a gentle nitrogen stream. The residue was dissolved in 250 ml acetonitrile. For derivatization, 30 ml HFIP and 20 ml DIC were added and incubated for 10 min at room temperature. Then, 1 ml sodium hydrogen carbonate solution (1 mol/l) and 250 ml iso-octane were added. The test tube was shaken vigorously and centrifuged for 5 min at 2000 Â g. Totally, 1 ml of the iso-octane phase was injected into GC/MS.
Apparatus and GC/MS Conditions
Separation analyses of CDCA and 3-PBA were performed by an Agilent 7890A equipped with 5975C inert MSD System (Agilent Technologies, Santa Clara, CA, USA). The GC operating conditions were as follows: GC column, Rtx-65 (Restek, Bellefonte, PA, USA), 30 m Â 0.25 mm i.d., 0.25 mm film thickness; column temperatures, 70 1C (3 min)-20 1C/min-290 1C (5 min); injection port temperature, 250 1C; carrier gas, helium (99.999% purity); flow rate, 1 ml/min. The injector was switched from the splitless mode to the split mode (50:1) 2 min after sample injection. MS operating conditions were as follows: ionization source temperature, 230 1C; electron ionization, 70 eV; interface temperature, 300 1C. The chromatogram peak was identified by target and quantifier ions for each [HFIP]-CDCA and -3-PBA as shown in Table 2 .
Pass Efficiency of PYR Metabolites Through the Top Sheet of Diapers
Excreted urine passes through the top sheet of a diaper before being absorbed by the urine absorber ( Figure 3 ). Therefore, it is necessary to examine whether or not PYR metabolites are absorbed into the top sheet. Urine spiked with PYR metabolites (20 mg/l) was passed through the top sheet removed from five diaper products (A-D) and collected into tubes. The urine sample passed through the sheet (after passage) and the original urine sample (before passage) were analyzed according to the previously reported method (n ¼ 5). 3 The efficiency of metabolite passage was evaluated by comparison of the pre-and post-passage urine samples.
Method Validation
Approximately 0.2 g urine absorbers were removed from the disposable diapers. Then, 2 ml of pooled urine spiked with known concentrations for metabolites was applied to the absorbers. After incubation for 1 h at room temperature, the urine absorbers were supplied for method validation.
The extraction efficiencies of PYR metabolites in diapers were determined by comparing analyte/IS peak area ratios obtained from the diaper method and from the direct method.
Calibration curves were prepared by plotting the analyte/IS peak area ratio versus the concentration of the standard spiked samples ranging from 0.1 to 20 mg/l for CDCA and from 0.4 to 20.4 mg/l for 3-PBA. Standards for all metabolites were analyzed in duplicate with each run. Calibration curves for CDCA and 3-PBA were generated by linear regression analysis. The within-series precision and between-day precision for our proposed method were examined through the assays of the pooled urine spiked with concentrations at 0.5, 2.0 and 20.0 mg/l for CDCA and 0.4, 0.9, 2.4 and 20.4 mg/l for 3-PBA (n ¼ 5) in urine absorbers. The between-day precision was examined through the duplicate assay for five consecutive days at the above-mentioned metabolite concentrations.
The LOD and the limit of quantification (LOQ) were calculated based on the signal-to-noise ratio of 3 for LOD and 10 for LOQ.
Cross-validation tests between the diaper method and the direct method were performed using adult urine samples obtained from the following two groups. The first group was a university student group, regarded as a representative population exposed to PYR at environmental levels (n ¼ 28). The second was a pest control operator (PCO) group, regarded as an occupational PYR exposure group (n ¼ 27). Urinary PYR metabolites in diapered children S Saito et al
The stabilities of PYR metabolites in urine absorbers were studied at 37 1C, 4 1C and À 80 1C. Three antioxidants, ascorbic acid, sodium disulfate and pyrogallol, were examined for possible effect on the degradation of PYR metabolites in diapers. These antioxidants were added to the urine absorbers before the addition of the spiked urine.
Sample Collection
Ten diapered children (6 neonates, 1 aged 9 months and 3 aged 2 years) born in Sendai and Nagoya, Japan, were recruited for this study. Six neonates delivered in Tohoku University Hospital wore Diaper E (see trade name in Table 1 ). Four children born in Nagoya used different diaper brands; 2 children wore diaper A, 1 diaper C and 1 diaper D. Ten diapers were collected from each of the above 10 children. Collected diaper samples were transported at À 20 1C to our laboratory, and then stored at À 80 1C until metabolite analyses. PYR metabolites in diapers were quantified using diaper-matched calibration curves.
Data and Statistical Analysis
Results were expressed as means ± SD. Statistical analysis was performed with the SPSS statistical package for Windows version 19 (SPSS, Chicago, IL, USA); two-sided P-values of o0.05 were considered statistically significant. Comparisons of PYR metabolite degradation level under some storage conditions were performed by paired Student's t-test.
RESULTS AND DISCUSSION

Pass Efficiency of Top Sheet for PYR Metabolites and Evaluation of Urine Volume in Urine Absorbers
The CDCA and 3-PBA concentrations of urine samples that passed through the top sheet of five diaper products ranged from 20±0.5 (mean ± SD) to 22 ± 0.6 mg/l for CDCA and from 19 ± 0.7 to 21 ± 0.5 mg/l for 3-PBA. Thus, the percentages of their passage ranged from 100% to 109% for CDCA and from 95% to 106% for 3-PBA. These data suggest that there is little absorption of PYR metabolites into the top sheets of the five diaper products, making it unnecessary to determine the PYR metabolites from the top sheet.
The urine volume in the urine absorber was evaluated at 103 ± 4% (mean ± SD) of the added urine volume. This evaluated urine volume was used as the correction factor for calculation of final concentration of urine after the GC/MS analytical procedure.
Method Validation
Hu et al. 7 found calcium chloride (CaCl 2 ) solution to be satisfactory in releasing metabolites from the polymers with B90% absolute recoveries for 3-PBA. Their method seems impractical to apply for high-throughput measurement assay because of the large volume of eluate solution (100 ml CaCl 2 solution) and difficulty in concentrating the eluate compared with solvent elution. We tested four extracting solutions, that is, hexane, acetone, acetonitrile and diethyl ether, with which the recovery of PYR metabolite from urine absorber in diapers could possibly be made. In fact, hexane extraction did not work. Among acetone, acetonitrile and diethyl ether, slightly higher recoveries were shown by a small volume of 5 ml acetone compared with other eluents (1.47 times higher recovery for 3-PBA than the other two), of which the mechanism was unclear. In addition, use of acetone for the eluent has two distinct advantages, that is, relatively high flash point and high volatility. High volatility of acetone can rapidly dry up SPE tube containing absorber, and soon concentrates the eluent. Thus, we selected acetone as an optimum eluent solution. Increasing the elution volume to 10 ml acetone did not dramatically improve the absolute recoveries.
Absolute recovery data are shown in Figure 4 . The recovered percentage of CDCA (10-74%) was lower than that of 3-PBA (74-123%). Lower recoveries of CDCA might be attributable to its relatively high polarity compared with the polarity of 3-PBA. Thus, the relatively low affinity of CDCA in eluate acetone resulted in the low recovery from diapers. Lower recoveries were shown for 0.5 mg/l CDCA in each diaper than for 2.0 mg/l CDCA. In contrast, the recoveries of the 2.4 mg/l 3-PBA were lower than those of 0.9 mg/l 3-PBA. A low margin of recoveries between the low and high metabolite concentrations was shown in diaper A for both CDCA and 3-PBA. Sensitivity and Precision Sensitivity and precision data are summarized in Table 3 . LOD and LOQ values were 0.03 and 0.09 mg/l for 3-PBA. These values are similar to the LOD levels reported by Leng et al. 6 and Fortin et al. 11 using GC/MS, and would be low enough for high-sensitivity detection. On the other hand, LOD and LOQ for CDCA were approximately three times higher than the previously reported values. 3 This may be caused by the low absolute recoveries of CDCA extracted from diapers ( Figure 4) .
Within-series precision was estimated by assaying the pooled urine spiked with 0.5-20.0 mg/l CDCA and with 0.4-20.4 mg/l 3-PBA; the coefficient of variations (CV%) ranged from 3.6 to 8.7% for CDCA and from 5.2 to 13.8% for 3-PBA. Moreover, between-day precision was between 4.2 and 8.1% (CV%) for CDCA and 3.7 and 11.7% for 3-PBA. These precision levels were almost the equivalent of, or lower than, those of the previous methods that measured urine that was not absorbed in diapers.
3,12 Figure 6 shows the typical single ion chromatograms of CDCA and 3-PBA from disposable diapers containing human urine (A, CDCA 20.0 mg/l; B, 3-PBA 20.4 mg/l). We found no chromatographic interference noise derived from diapers (data not shown). However, when measuring the metabolites extracted from some used diapers, we observed some peaks interfering around the analytes (C, CDCA 0.5 mg/l; D, 3-PBA 0.2 mg/l). Abbreviations: CDCA, trans-chrysanthemumdicarboxylic acid; C-ion, selected ion for confirmation; IS, internal standard; m/z, mass/charge ratio; Q-ion, selected ion for quantification; 2-PBA, 2-phenoxybenzoic acid; 3-PBA, 3-phenoxybenzoic acid.
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Cross-Validation Test
The above-mentioned variation data were tested using PYR metabolites obtained commercially as free forms (non-conjugated form). Large amounts of CDCA and 3-PBA are excreted in a form conjugated with glucuronic acid, glycine and sulfate, 2, 5 suggesting that the validation assay of conjugated-form metabolites might differ from the validation data of free-form metabolites. Therefore, our method (diaper method) results were compared with the results from the direct method using actual urine samples containing wide-ranging concentrations of PYR metabolites (free, glucuronide, glycine and sulfate forms).
The PYR metabolites in urine obtained from people with occupational and non-occupational PYR exposures were assayed with the diaper method and the direct method. Detection frequencies were 79% for CDCA and 100% for 3-PBA in the general population, and were 100% for both CDCA and 3-PBA in PCOs. The dashed lines in Figure 7 represent an ideal line with a slope of 1 and an intercept of 0. Spearman's rank correlation coefficient showed good agreement, suggesting that urinary conjugated PYR metabolites in the diapers were sufficiently extracted. Moreover, these results also suggest that our diaper method is insusceptible to matrix variability of urine samples.
As mentioned above, the diaper method for the measurement of wide-ranging concentrations of PYR metabolite in urine collected from different populations yielded high accuracy, precision and sensitivity free of influence from various urine matrixes. Urinary PYR metabolites in diapered children S Saito et al
Sample Stability in Diapers
As the storage condition of used diapers is uncontrollable outside laboratories, it is important to assess the analyte stability at room temperature. Although many studies have focused on the degradation of PYR in various environmental conditions and in biological samples, 13, 14 little is known about the stability of PYR metabolites. We carried out the PYR metabolite stability assay at 37 1C on the assumption that used diapers could be stored at high temperatures as in the summer daytime. The concentration-time curves of urinary PYR metabolites in diapers at 37 1C (under dark condition) are illustrated in Figure 8 . Significant degradations of the PYR metabolites are not shown at respective concentrations of Low concentration levels of 3-PBA in diapers were significantly decreased 6 h after incubation at 37 1C. This degradation of 3-PBA was also found in urine sample stored at 37 1C (data not shown), suggesting that components of the diapers did not affect 3-PBA stability at low concentration levels. On the other hand, no 3-PBA degradation was found when the samples were stored at 4 1C, À 30 1C and À 80 1C. Considering that the geometric mean of urinary 3-PBA concentration in Japanese adults was B0.3 mg/l, 15 the 3-PBA concentration of children wearing diapers might be at a similar level. Therefore, it is preferable to store urine and used diapers at a temperature as low as possible.
Effect of Antioxidants on Degradation of 3-PBA in Diapers Oxidation is the most common cause of analyte degradation in urine samples. As shown in Figure 9 , 3-PBA degradation was significantly suppressed by the addition of antioxidant sodium disulfate and pyrogallol to diapers before pouring urine on the diapers (Figure 9a) , suggesting that the cause of 3-PBA degradation in urine or used diapers might be oxidation. We decided to choose the antioxidant sodium disulfate as the inhibitor for 3-PBA degradation because pyrogallol affected the measurement precision of urinary 3-PBA extracted from used diapers. To minimize the added amount of sodium disulfate into the urine absorbers, the association between the amount of sodium disulfate and 3-PBA degradation was tested. The results indicated that more than 5 mg sodium disulfate per 0.2 g urine absorber was needed to inhibit 3-PBA degradation (Figure 9b ).
Application of Methods to Used Diaper Samples
Preliminary application of the established method to the diapers used by the children revealed detection frequencies of 50% for CDCA and 100% for 3-PBA, respectively. Geometric means and median values were 0.19 mg/l (assign the value 0.09 to nondetectable samples) and 0.21 mg/l for CDCA and 0.35 and 0.37 mg/l for 3-PBA, respectively. There have been no reported data so far to compare with our data on CDCA and 3-PBA concentrations detected from children at this time; only a few research teams have tried to measure the biochemical or xenobiotic markers in urine extracted from used diapers. [16] [17] [18] One research group has reported the concentration of urinary CDCA in 120 children aged 6 to 12 years to be 0.05 mg/l (median). 11 Becker et al. 19 reported that the geometric mean of urinary 3-PBA concentrations in children aged between 2 and 5 years was 0.34 mg/l. These data were approximately at the same or lower levels compared with our data. Further study is needed to clarify the characteristics of urinary PYR metabolites in infants including diapered babies.
There are some points to be noted. Concentrations in different parts of one diaper were approximately the same when we measured PYR metabolites using different parts of the absorbers obtained from a diaper sample. In this regard, we recommend duplicate or triplicate absorber sampling from a diaper for more reliable results. Second, the diaper brands used for preparing calibration curves need to be matched with the actual diaper samples obtained from children as calibration slopes obtained from various commercial diapers are different. Third, the diaper samples need large storage spaces compared with urine samples. Finally, it is difficult to measure urinary creatinine that is used to Figure 8 . Storage stability test of urinary CDCA and 3-PBA in diapers at 37 1C. Each point represents the mean±SD of three or four separate experiments (100% for level of peak area after pre-incubation samples (0 h)) derived from independent preparations. *Significantly different from level of 0 h peak area (Po0.05). correct the effects of urine dilution. Given the low cost and ease of operation, the Jaffe method has been used for urinary creatinine assay in many countries, and is presented as a standard method by the World Health Organization. However, this method is not applicable for the eluate of urine from used diapers because of the presence of acetone. Further study is needed to develop a measurement method for creatinine from the eluate of urine from used diapers by means other than the Jaffe method. In this regard, the measurement of excreted metabolites using 24-h urine recovered from all the diapers on a given day could reveal the exact metabolite excretion level, as our ''diaper method'' and the conventional ''direct method'' yielded almost identical results.
CONCLUSION
We have developed a simple, precise and highly sensitive (detectable for environmental exposure level) method for the simultaneous quantitation of urinary PYR metabolites CDCA and 3-PBA from used diapers, and have applied this method to assess PYR exposure in young children. In exposure studies in children, urine is the preferred sample for biomonitoring, having advantages over blood in its non-invasiveness and ease of collection. Therefore, this promising measurement method may contribute to future epidemiological studies of the risk assessment of PYR exposure among diapered children.
